Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 "PembroRad" randomized trial

被引：51

作者：

Bourhis, J. ^{[1
]}

Sire, C. ^{[2
]}

Tao, Y. ^{[3
]}

Martin, L. ^{[4
]}

Alfonsi, M. ^{[5
]}

Prevost, J. B. ^{[6
]}

Rives, M. ^{[7
]}

Lafond, C. ^{[8
]}

Tourani, J. M. ^{[9
]}

Biau, J. ^{[10
]}

Geoffrois, L. ^{[11
]}

Coutte, A. ^{[12
]}

Liem, X. ^{[13
]}

Vauleon, E. ^{[14
]}

Drouet, F. ^{[15
]}

Pechery, A. ^{[16
]}

Guigay, J. ^{[17
]}

Wanneveich, M. ^{[16
]}

Auperin, A. ^{[3
]}

Sun, X. ^{[18
]}

机构：

[1] CHU Vaudois, Radiat Oncol, Lausanne, Switzerland

[2] CHU Bretagne Sud, Lorient, France

[3] Inst Gustave Roussy, Radiat Oncol, Villejuif, France

[4] Clin Ormeaux, Le Havre, France

[5] Inst St Catherine, Avignon, France

[6] Ctr Pierre Curie, Beuvry, France

[7] Inst Claudius Regaud, Toulouse, France

[8] Clin Victor Hugo, Le Mans, France

[9] CHU Poitiers, Hop Jean Bernard, Poitiers, France

[10] Ctr Lutte Canc J Perrin, Clermont Ferrand, France

[11] Inst Cancerol Lorraine Alexis Vautrin, Med Oncol, Vandoeuvre Les Nancy, France

[12] CHU Amiens Picardie Site Sud, Radiat Oncol, Amiens, France

[13] Ctr Oscar Lambret, Radiotherapy, Lille, France

[14] Ctr Eugene Marquis, Rennes, France

[15] Clin Mutualiste Estuaire, St Nazaire, France

[16] CHU Bretonneau, GORTEC, Tours, France

[17] Ctr Anticanc Antoine Lacassagne, Med Oncol Dept, Nice, France

[18] Hop Nord Franche Comte, Belfort, France

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷

关键词：

D O I：

10.1016/j.annonc.2020.08.2268

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA38

引用

页码：S1168 / S1168

页数：1